These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35029910)

  • 1. Long-term outcomes of large artery thromboangiitis obliterans and comparison with small artery thromboangiitis obliterans.
    Lee SA; Jeong MJ; Ko GY; Hwang HS; Gwon DI; Choi E; Kwon TW; Cho YP
    Medicine (Baltimore); 2022 Jan; 101(1):e28512. PubMed ID: 35029910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endovascular Treatment of Critical Limb Ischemia in Buerger Disease (Thromboangiitis Obliterans) With Midterm Follow-Up: A Viable Option When Bypass Surgery Is Not Feasible.
    Uyanık SA; Öğüşlü U; Aminu IS; Yılmaz B; Çevik H; Atlı E; Gümüş B
    AJR Am J Roentgenol; 2021 Feb; 216(2):421-427. PubMed ID: 33325735
    [No Abstract]   [Full Text] [Related]  

  • 3. Outcomes of endovascular treatment versus bypass surgery for critical limb ischemia in patients with thromboangiitis obliterans.
    Lee CY; Choi K; Kwon H; Ko GY; Han Y; Kwon TW; Cho YP
    PLoS One; 2018; 13(10):e0205305. PubMed ID: 30300407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up of thromboangiitis obliterans.
    Börner C; Heidrich H
    Vasa; 1998 May; 27(2):80-6. PubMed ID: 9612110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of endovascular recanalization versus autogenous venous bypass for thromboangiitis obliterans patients with critical limb ischemia due to tibioperoneal arterial occlusion.
    Ye K; Shi H; Qin J; Yin M; Liu X; Li W; Jiang M; Lu X
    J Vasc Surg; 2017 Oct; 66(4):1133-1142.e1. PubMed ID: 28697938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endovascular Recanalization of Thromboangiitis Obliterans (Buerger's Disease) in Twenty-Eight Consecutive Patients and Combined Antegrade-Retrograde Intervention in Eight Patients.
    Firat A; Igus B
    Cardiovasc Intervent Radiol; 2019 Jun; 42(6):820-828. PubMed ID: 30834476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endovascular Therapy Outcomes and Intravascular Ultrasound Findings in Thromboangiitis Obliterans (Buerger's Disease).
    Kawarada O; Kume T; Ayabe S; Nakaya T; Nakai M; Nishimura K; Noguchi T; Yokoi Y; Ogawa H; Yasuda S
    J Endovasc Ther; 2017 Aug; 24(4):504-515. PubMed ID: 28743226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Clinical Outcomes of Autologous Bone Marrow Mononuclear Cell Implantation in Patients With Severe Thromboangiitis Obliterans.
    Mohamad Yusoff F; Kajikawa M; Takaeko Y; Kishimoto S; Hashimoto H; Maruhashi T; Kihara Y; Nakashima A; Higashi Y
    Circ J; 2020 Mar; 84(4):650-655. PubMed ID: 32132348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herbal therapy treatment in thromboangiitis obliterans: a retrospective clinical study.
    Li G; Zefr C; Yang B; He C; Hafner F; Pang H
    Ann Palliat Med; 2020 Jul; 9(4):1696-1707. PubMed ID: 32692190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of arterial involvement and feasibility of revascularization in thromboangiitis obliterans: a tertiary care centre experience.
    Dsouza RJ; Premkumar P; Samuel V; Kota A; Agarwal S
    ANZ J Surg; 2020 Dec; 90(12):2506-2509. PubMed ID: 33176048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endovascular Treatment of Thromboangiitis Obliterans (Buerger's Disease).
    Modaghegh MS; Hafezi S
    Vasc Endovascular Surg; 2018 Feb; 52(2):124-130. PubMed ID: 29237360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cannabis consumption on characteristics and evolution of thromboangitis obliterans.
    Bergère G; Toquet C; Hoffmann C; Bressollette L; Raimbeau A; Durant C; Artifoni M; Gautier G; Hersant J; Connault J; Pistorius MA; Espitia O
    Vasa; 2021 Jul; 50(4):301-305. PubMed ID: 33739143
    [No Abstract]   [Full Text] [Related]  

  • 13. Visceral bed involvement in thromboangiitis obliterans: a systematic review.
    Fakour F; Fazeli B
    Vasc Health Risk Manag; 2019; 15():317-353. PubMed ID: 31616151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Endovascular Radiofrequency Ablation for Thromboangiitis Obliterans (Buerger's Disease).
    Tang J; Gan S; Zheng M; Jiang Y; Feng Y; Miao J
    Ann Vasc Surg; 2017 Jul; 42():78-83. PubMed ID: 28341508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Revascularization for lower limbs thromboangiitis obliterans-early and mid-term outcome report].
    Zeng R; Ye W; Li YJ; Shao J; Zheng YH; Liu CW
    Zhonghua Wai Ke Za Zhi; 2013 Aug; 51(8):719-22. PubMed ID: 24252679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conservative treatment of patients with thromboangiitis obliterans or cannabis-associated arteritis presenting with critical lower limb ischaemia.
    Galyfos G; Kerasidis S; Kastrisios G; Giannakakis S; Sachmpazidis I; Anastasiadou C; Geropapas G; Papapetrou A; Papacharalampous G; Maltezos C
    Vasa; 2017 Oct; 46(6):471-475. PubMed ID: 28753096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Outcome and Prognostic Factors of Complications in Thromboangiitis Obliterans (Buerger's Disease): A Multicenter Study of 224 Patients.
    Le Joncour A; Soudet S; Dupont A; Espitia O; Koskas F; Cluzel P; Hatron PY; Emmerich J; Cacoub P; Resche-Rigon M; Lambert M; Saadoun D;
    J Am Heart Assoc; 2018 Dec; 7(23):e010677. PubMed ID: 30571594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Did the Clinical Spectrum of Thromboangiitis Obliterans Change in the Past 40 Years?
    Soudet S; Le Joncour A; Quemeneur T; Maillard H; Koskas F; Hachulla E; Cacoub P; Yelnik CM; Saadoun D; Lambert M
    Angiology; 2020 Aug; 71(7):621-625. PubMed ID: 32319306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained classic clinical spectrum of thromboangiitis obliterans (Buerger's disease).
    Wysokinski WE; Kwiatkowska W; Sapian-Raczkowska B; Czarnacki M; Doskocz R; Kowal-Gierczak B
    Angiology; 2000 Feb; 51(2):141-50. PubMed ID: 10701722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demographic Traits, Clinical Status, and Comorbidities of Patients With Thromboangiitis Obliterans in Japan.
    Watanabe Y; Shimizu Y; Hashimoto T; Iwahashi T; Shigematsu K; Nakaoka Y; Harigai M;
    Circ J; 2024 Feb; 88(3):319-328. PubMed ID: 37423757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.